Prudential Financial’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-117,396
Closed -$9.97M 2508
2019
Q4
$9.97M Buy
117,396
+720
+0.6% +$48K 0.01% 861
2019
Q3
$5.83M Buy
116,676
+4,920
+4% +$196K 0.01% 1045
2019
Q2
$4.08M Buy
111,756
+5,340
+5% +$174K 0.01% 1250
2019
Q1
$2.97M Sell
106,416
-636
-0.6% -$15K ﹤0.01% 1393
2018
Q4
$2.05M Sell
107,052
-2,610
-2% -$60.7K ﹤0.01% 1502
2018
Q3
$3.28M Sell
109,662
-80
-0.1% -$3.01K ﹤0.01% 1384
2018
Q2
$4.03M Buy
109,742
+720
+0.7% +$23.4K 0.01% 1311
2018
Q1
$3.59M Buy
109,022
+2,650
+2% +$82.8K 0.01% 1303
2017
Q4
$2.91M Sell
106,372
-2,070
-2% -$63.8K ﹤0.01% 1410
2017
Q3
$4.02M Sell
108,442
-12,940
-11% -$477K 0.01% 1242
2017
Q2
$4.61M Sell
121,382
-1,170
-1% -$52.1K 0.01% 1176
2017
Q1
$5.99M Buy
122,552
+3,390
+3% +$155K 0.01% 1053
2016
Q4
$4.04M Sell
119,162
-11,999
-9% -$426K 0.01% 1205
2016
Q3
$4.95M Sell
131,161
-44,930
-26% -$1.69M 0.01% 1072
2016
Q2
$5.92M Buy
176,091
+6,541
+4% +$231K 0.01% 1014
2016
Q1
$5.39M Buy
169,550
+8,638
+5% +$282K 0.01% 1058
2015
Q4
$6.01M Buy
160,912
+8,000
+5% +$302K 0.01% 1002
2015
Q3
$5.8M Buy
152,912
+1,820
+1% +$63.9K 0.01% 956
2015
Q2
$4.32M Buy
151,092
+4,000
+3% +$111K 0.01% 1174
2015
Q1
$4.12M Sell
147,092
-700
-0.5% -$19.7K 0.01% 1233
2014
Q4
$4.09M Buy
147,792
+3,900
+3% +$96.6K 0.01% 1099
2014
Q3
$3.21M Sell
143,892
-9,552
-6% -$243K 0.01% 1161
2014
Q2
$4.46M Buy
153,444
+6,052
+4% +$162K 0.01% 1061
2014
Q1
$4.19M Buy
147,392
+2,500
+2% +$82.7K 0.01% 1049
2013
Q4
$5.6M Buy
144,892
+2,780
+2% +$99.4K 0.01% 919
2013
Q3
$4.76M Buy
142,112
+17,220
+14% +$549K 0.01% 960
2013
Q2
$3.84M Buy
+124,892
New +$4.18M 0.01% 1015

Other funds holding MDCO

Prudential Financial's MDCO Position: Q1 2020 in Review

Prudential Financial sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 117,396 shares — an estimated $9.97M sold.

Prudential Financial first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $9.97M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Prudential Financial reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Prudential Financial sold 117,396 Medicines Co shares in Q1 2020, an estimated $9.97M.
  • Prudential Financial first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
  • Prudential Financial's Medicines Co position peaked at $9.97M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Prudential Financial's 13F filing for Q1 2020, filed 12 May 2020.